Feedback / Questions
fluticasone propionate controlled release (EP-104) - Eupraxia Pharma
https://www.globenewswire.com/news-release/2025/11/13/3187915/0/en/Eupraxia-Pharmaceuticals-Reports-Additional-52-week-Follow-up-Data-from-the-RESOLVE-Trial-in-Eosinophilic-Esophagitis-EoE-Demonstrating-Consistent-Results-after-Dosing-with-EP-104G.html
Nov 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next